Victoria Llado Canellas
Chief Strategy Officer Laminar Pharma Inc
Seminars
Thursday 19th February 2026
A Novel Approach for Glioma Therapy: Targeting Cell Membrane Lipids with Melitherapy
9:00 am
- Innovating Melitherapy as a platform that specifically targets lipids within the cell membrane, offering a unique approach that contrasts with traditional protein-focused drug design
- Using synthetic fatty acids to modify the composition and fluidity of the cell membrane, which interferes with membrane-associated proteins responsible for disease processes like tumor growth
- Sharing MIN-001-1203 trial of 2-hydroxyoleic acid in patients with advanced solid tumors, including malignant glioma, has shown very promising results, highlighting the potential for significant clinical benefit
